These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 18446436

  • 1. The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
    Cao AY, Huang J, Hu Z, Li WF, Ma ZL, Tang LL, Zhang B, Su FX, Zhou J, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Yuan WT, Shen ZZ, Huang W, Shao ZM.
    Breast Cancer Res Treat; 2009 Apr; 114(3):457-62. PubMed ID: 18446436
    [Abstract] [Full Text] [Related]

  • 2. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
    Cao AY, Huang J, Hu Z, Li WF, Ma ZL, Tang LL, Zhang B, Su FX, Zhou J, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Yuan WT, Shen ZZ, Huang W, Shao ZM.
    Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
    [Abstract] [Full Text] [Related]

  • 3. PALB2 mutations 1592delT and 229delT are not present in Korean breast cancer patients negative for BRCA1 and BRCA2 mutations.
    Kim JH, Choi DH, Cho DY, Ahn SH, Son BH, Haffty BG.
    Breast Cancer Res Treat; 2010 Jul; 122(1):303-6. PubMed ID: 20213081
    [Abstract] [Full Text] [Related]

  • 4. The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified.
    Li WF, Hu Z, Rao NY, Song CG, Zhang B, Cao MZ, Su FX, Wang YS, He PQ, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Liu XY, Zhou J, Wang L, Zhao L, Liu YB, Yuan WT, Yang L, Shen ZZ, Huang W, Shao ZM.
    Breast Cancer Res Treat; 2008 Jul; 110(1):99-109. PubMed ID: 17851763
    [Abstract] [Full Text] [Related]

  • 5. Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.
    García MJ, Fernández V, Osorio A, Barroso A, Llort G, Lázaro C, Blanco I, Caldés T, de la Hoya M, Ramón Y Cajal T, Alonso C, Tejada MI, San Román C, Robles-Díaz L, Urioste M, Benítez J.
    Breast Cancer Res Treat; 2009 Feb; 113(3):545-51. PubMed ID: 18302019
    [Abstract] [Full Text] [Related]

  • 6. [Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai].
    Song CG, Hu Z, Yuan WT, Di GH, Shen ZZ, Huang W, Shao ZM.
    Zhonghua Yi Xue Za Zhi; 2005 Nov 16; 85(43):3030-4. PubMed ID: 16324400
    [Abstract] [Full Text] [Related]

  • 7. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
    Gallardo M, Silva A, Rubio L, Alvarez C, Torrealba C, Salinas M, Tapia T, Faundez P, Palma L, Riccio ME, Paredes H, Rodriguez M, Cruz A, Rousseau C, King MC, Camus M, Alvarez M, Carvallo P.
    Breast Cancer Res Treat; 2006 Jan 16; 95(1):81-7. PubMed ID: 16261400
    [Abstract] [Full Text] [Related]

  • 8. PALB2 analysis in BRCA2-like families.
    Adank MA, van Mil SE, Gille JJ, Waisfisz Q, Meijers-Heijboer H.
    Breast Cancer Res Treat; 2011 Jun 16; 127(2):357-62. PubMed ID: 20582465
    [Abstract] [Full Text] [Related]

  • 9. Contribution of BRCA1 and BRCA2 germline mutations to the incidence of early-onset breast cancer in Cyprus.
    Loizidou M, Marcou Y, Anastasiadou V, Newbold R, Hadjisavvas A, Kyriacou K.
    Clin Genet; 2007 Feb 16; 71(2):165-70. PubMed ID: 17250666
    [Abstract] [Full Text] [Related]

  • 10. [Germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in China Han people].
    Zhou YZ, Sun Q, Lin SQ, Wang J, Liu B, Li JX, Zhou YD, Ye J, Han H, Fang FD.
    Zhonghua Yi Xue Za Zhi; 2004 Feb 17; 84(4):294-8. PubMed ID: 15059511
    [Abstract] [Full Text] [Related]

  • 11. Similar contributions of BRCA1 and BRCA2 germline mutations to early-onset breast cancer in Germany.
    Hamann U, Liu X, Bungardt N, Ulmer HU, Bastert G, Sinn HP.
    Eur J Hum Genet; 2003 Jun 17; 11(6):464-7. PubMed ID: 12774040
    [Abstract] [Full Text] [Related]

  • 12. Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer.
    Hellebrand H, Sutter C, Honisch E, Gross E, Wappenschmidt B, Schem C, Deissler H, Ditsch N, Gress V, Kiechle M, Bartram CR, Schmutzler RK, Niederacher D, Arnold N, Meindl A.
    Hum Mutat; 2011 Jun 17; 32(6):E2176-88. PubMed ID: 21618343
    [Abstract] [Full Text] [Related]

  • 13. The contribution of founder mutations to early-onset breast cancer in French-Canadian women.
    Ghadirian P, Robidoux A, Zhang P, Royer R, Akbari M, Zhang S, Fafard E, Costa M, Martin G, Potvin C, Patocskai E, Larouche N, Younan R, Nassif E, Giroux S, Narod SA, Rousseau F, Foulkes WD.
    Clin Genet; 2009 Nov 17; 76(5):421-6. PubMed ID: 19863560
    [Abstract] [Full Text] [Related]

  • 14. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
    Potapova A, Hoffman AM, Godwin AK, Al-Saleem T, Cairns P.
    Cancer Res; 2008 Feb 15; 68(4):998-1002. PubMed ID: 18281473
    [Abstract] [Full Text] [Related]

  • 15. A recurrent mutation in PALB2 in Finnish cancer families.
    Erkko H, Xia B, Nikkilä J, Schleutker J, Syrjäkoski K, Mannermaa A, Kallioniemi A, Pylkäs K, Karppinen SM, Rapakko K, Miron A, Sheng Q, Li G, Mattila H, Bell DW, Haber DA, Grip M, Reiman M, Jukkola-Vuorinen A, Mustonen A, Kere J, Aaltonen LA, Kosma VM, Kataja V, Soini Y, Drapkin RI, Livingston DM, Winqvist R.
    Nature; 2007 Mar 15; 446(7133):316-9. PubMed ID: 17287723
    [Abstract] [Full Text] [Related]

  • 16. Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals--correlation with clinicopathological data.
    Kataki A, Gomatos I, Pararas N, Armakolas A, Panousopoulos D, Karantzikos G, Voros D, Zografos G, Markopoulos C, Leandros E, Konstadoulakis M.
    Clin Genet; 2005 Apr 15; 67(4):322-9. PubMed ID: 15733268
    [Abstract] [Full Text] [Related]

  • 17. Spectrum and prevalence of BRCA1 and BRCA2 germline mutations in Sardinian patients with breast carcinoma through hospital-based screening.
    Palomba G, Pisano M, Cossu A, Budroni M, Dedola MF, Farris A, Contu A, Baldinu P, Tanda F, Palmieri G.
    Cancer; 2005 Sep 15; 104(6):1172-9. PubMed ID: 16047344
    [Abstract] [Full Text] [Related]

  • 18. The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer.
    Janatova M, Kleibl Z, Stribrna J, Panczak A, Vesela K, Zimovjanova M, Kleiblova P, Dundr P, Soukupova J, Pohlreich P.
    Cancer Epidemiol Biomarkers Prev; 2013 Dec 15; 22(12):2323-32. PubMed ID: 24136930
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer.
    Blanco A, de la Hoya M, Balmaña J, Ramón y Cajal T, Teulé A, Miramar MD, Esteban E, Infante M, Benítez J, Torres A, Tejada MI, Brunet J, Graña B, Balbín M, Pérez-Segura P, Osorio A, Velasco EA, Chirivella I, Calvo MT, Feliubadaló L, Lasa A, Díez O, Carracedo A, Caldés T, Vega A.
    Breast Cancer Res Treat; 2012 Feb 15; 132(1):307-15. PubMed ID: 22052327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.